Terms of Use


The documents contained in (or directly accessible from) this website include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the Company’s plans, objectives and strategies and any other statements containing the words “believes”, “expects”, “anticipates”, “plans”, “estimates” and similar expressions.

There are a number of important factors that could cause the Company’s actual results to differ materially from those indicated by such forward-looking statements, including whether the Company’s product candidates will advance into or through the clinical trial process on a timely basis or at all and receive approval from the United States Food and Drug Administration or equivalent foreign regulatory agencies; whether the Company will complete enrollment of clinical trials or announce trial results in the time expected; whether, if the Company’s products receive approval, they will be successfully distributed and marketed; whether the results of preclinical studies and early clinical trials will be indicative of results that may be obtained in clinical trials; whether the patents and patent applications owned or licensed by the Company will protect the Company’s product candidates and technology and prevent others from infringing them or it; whether the Company’s cash resources will be sufficient to fund product development and clinical trials and other factors identified under the caption “Risk Factors” in the Company’s filings with the SEC. The Company disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date such statement was first made.